Acquisition of Ly49 receptor expression by developing natural killer cells

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 609-618

  Dorfman, Jeffrey R ^a,b   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL TRANSFER; CONTROLLED STUDY; FETUS; FETUS CELL; LIVER CELL; MOUSE; NATURAL KILLER CELL; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS; ANTIGENS, LY; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTORS, IMMUNOLOGIC; SPLEEN;

EID: 0032536369     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.609     Document Type: Article

References (40)

1. Ljunggren, H.G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today. 11:237-244.
2. Yokoyama, W.M., and W.E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11:613-635.
3. Brennan, J., D. Mager, W. Jefferies, and F. Takei. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287-2295.
4. Held, W., J.R. Dorfman, M.-F. Wu, and D.H. Raulet. 1996. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26:2286-2292.
5. Mason, L.H., J.R. Ortaldo, H.A. Young, V. Kumar, M. Bennett, and S.K. Anderson. 1995. Cloning and functional characteristics of murine LGL-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182:293-303.
6. Raulet, D.H., W. Held, I. Correa, J. Dorfman, M.-F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41-52.
7. Salcedo, M., A.D. Diehl, M.Y. Olsson-Alheim, J. Sundbäck, L. Van Kaer, K. Kärre, and H.-G. Ljunggren. 1997. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I deficient mice. J. Immunol. 158:3174-3180.
8. Held, W., and D.H. Raulet. 1997. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in NK cell development. J. Exp. Med. 185:2079-2088.
9. Cudkowicz, G. 1975. Rejection of bone marrow allografts by irradiated athymic nude mice. Proc. Am. Assoc. Cancer Res. 16:170.
10. Murphy, W., V. Kumar, and M. Bennett. 1987. Rejection of bone marrow allografts by mice with severe combined immunodeficiency (SCID). J. Exp. Med. 165:1212-1217.
11. Sánchez, M.J., M.O. Muench, M.G. Roncarolo, L.L. Lanier, and J.H. Phillips. 1994. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180:569-576.
12. Rodewald, H.R., P. Moingeon, J.L. Lucich, C. Dosiou, P. Lopez, and E.L. Reinherz. 1992. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells. Cell. 69:139-150.
13. 89Sr: normal target-binding cell numbers but inability to kill even after interferon administration. J. Immunol. 123:1832-1838.
14. + cells. J. Immunol. 136:3124-3131.
15. Puzanov, I.J., M. Bennett, and V. Kumar. 1996. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157:4282-4285.
16. Fowlkes, B.J., L. Edison, B.J. Mathieson, and T.M. Chused. 1985. Early T lymphocytes. Differentiation in vivo of adult intrathymic precursor cells. J. Exp. Med. 162:802-822.
17. Scollay, R., A. Wilson, A. D'Amico, K. Kelly, M. Egerton, M. Pearse, L. Wu, and K. Shortman. 1988. Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol. Rev. 104:81-120.
18. Ceredig, K., J. Lowenthal, M. Nabholz, and H.R. MacDonald. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 314: 98-100.
19. Raulet, D.H., P. Gottlieb, and M.J. Bevan. 1980. Fractionation of lymphocyte population with monoclonal antibodies specific for Lyt-2.2 and Lyt-3.1. J. Immunol. 125:1136-1143.
20. Symington, F., and J. Sprent. 1981. A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion. Immunogenetics. 14:53-61.
21. Koo, G.C., and J.R. Peppard. 1984. Establishment of monoclonal anti-NK-1.1 antibody. Hybridoma. 3:301-303.
22. + thymocytes. Nature. 330:170-173.
23. Perussia, B., M.M. Tutt, W.Q. Qiu, W.A. Kuziel, P.W. Tucker, G. Trinchieri, M. Bennett, J.V. Ravetch, and V. Kumar. 1989. Murine natural killer cells express functional FcγRII encoded by the FcγR α gene. J. Exp. Med. 170:73-86.
24. Nagasawa, R., J. Gross, O. Kanagawa, K. Townsend, L.L. Lanier, J. Chiller, and J.P. Allison. 1987. Identification of a novel T cell surface disulfide-bonded dimer distinct from the α/β antigen receptor. J. Immunol. 138:815-824.
25. Roland, J., and P.A. Cazenave. 1992. Ly-49 antigen defines an αβ TCR population in i-IEL with an extrathymic maturation. Int. Immunol. 4:699-706.
26. Sentman, C.L., J.J. Hackett, T.A. Moore, M.M. Tutt, M. Bennett, and V. Kumar. 1989. Pan natural killer cell monoclonal antibodies and their relationship to the NK1.1 antigen. Hybridoma. 8:605-614.
27. Brennan, J., S. Lemieux, J. Freeman, D. Mager, and F. Takei. 1996. Heterogeneity among Ly49C NK cells: characterization of highly related receptors with differing functions and expression patterns. J. Exp. Med. 184:2085-2090.
28. Mason, L., S. Giardina, T. Hecht, J. Ortaldo, and B. Mathieson. 1988. LGL-1: a non polymorphic antigen expressed on a major population of mouse natural killer cells. J. Immunol. 140:4403-4412.
29. Cudkowicz, G., and M. Bennett. 1971. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J. Exp. Med. 134:1513-1528.
30. Kiessling, R., P.S. Hochman, O. Haller, G.M. Shearer, H. Wigzell, and G. Cudkowicz. 1977. Evidence for a similar or common mechanisms for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7:655-663.
31. Takei, F., J. Brennan, and D.L. Mager. 1997. The Ly49 family: genes proteins and recognition of class I MHC. Immunol. Rep. 155:67-77.
32. George, T., Y.Y.L. Yu, J. Liu, C. Davenport, S. Lemieux, E. Stoneman, P.A. Mathew, V. Kumar, and M. Bennett. 1997. Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone marrow grafts. Immunol. Rev. 155:29-40.
33. Vance, R.E., D.M. Tanamachi, T. Hanke, and D.H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27:3236-3241.
34. Lanier, L.L. 1997. Natural killer cells: from no receptors to too many. Immunity. 6:371-378.
35. Fáhlen, L., N.K.S. Khoo, M.R. Daws, and C.L. Sentman. 1997. Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules. Eur. J. Immunol. 27:2057-2065.
36. Garrido, F., T. Cabrera, A. Concha, S. Glew, F. Ruiz-Cabello, and P. Stern. 1993. Natural history of HLA expression during tumour development. Immunol. Today. 14:491-499.
37. Vance, R.E., and D.H. Raulet. 1997. Towards a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Curr. Top. Microbiol. Immunol. In press.
38. - mice. J. Immunol. 159:5219-5225.
39. Held, W., and D.H. Raulet. 1997. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur. J. Immunol. 27:2876-2884.
40. Johansson, M.H., C. Bieberich, G. Jay, K. Kärre, and P. Hoglund. 1997. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J. Exp. Med. 186:353-364.